|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/337 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/282 | (2006.01) | ||
| A61K 33/24 | (2006.01) | ||
| A61K 31/7072 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/51 | (2006.01) |
| (11) | Number of the document | 2481405 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12154995.0 |
| Date of filing the European patent application | 2007-11-06 | |
| (97) | Date of publication of the European application | 2012-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-23 |
| (46) | Date of publication of the claims translation | 2016-06-27 |
| (30) | Number | Date | Country code |
| 594417 | 2006-11-06 | US |
| (72) |
Desai, Neil P., US
Soon-Shiong, Patrick, US
|
| (73) |
Abraxis BioScience, LLC,
11755 Wilshire Boulevard, Suite 2100, Los Angeles, CA 90025,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Paklitakselio ir albumino nanodalelės derinyje su bevacizumabu, skirtame panaudoti prieš vėžį |
| Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| Payment date | Validity (years) | Amount | |
| 2025-10-03 | 19 | 347.00 EUR |
| 2026-11-06 |